- Home
- TNGX vs WEYS Comparison
TNGX vs WEYS Comparison
Compare TNGX & WEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- WEYS
- Stock Information
- Founded
- TNGX 2014
- WEYS 1906
- Country
- TNGX United States
- WEYS United States
- Employees
- TNGX N/A
- WEYS N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- WEYS Apparel
- Sector
- TNGX Health Care
- WEYS Consumer Staples
- Exchange
- TNGX Nasdaq
- WEYS Nasdaq
- Market Cap
- TNGX 317.4M
- WEYS 349.8M
- IPO Year
- TNGX N/A
- WEYS N/A
- Fundamental
- Price
- TNGX $3.35
- WEYS $35.53
- Analyst Decision
- TNGX Strong Buy
- WEYS
- Analyst Count
- TNGX 8
- WEYS 0
- Target Price
- TNGX $13.14
- WEYS N/A
- AVG Volume (30 Days)
- TNGX 757.1K
- WEYS 10.0K
- Earning Date
- TNGX 03-17-2025
- WEYS 03-04-2025
- Dividend Yield
- TNGX N/A
- WEYS 8.56%
- EPS Growth
- TNGX N/A
- WEYS N/A
- EPS
- TNGX N/A
- WEYS 3.02
- Revenue
- TNGX $43,383,000.00
- WEYS $290,409,000.00
- Revenue This Year
- TNGX $27.73
- WEYS N/A
- Revenue Next Year
- TNGX N/A
- WEYS N/A
- P/E Ratio
- TNGX N/A
- WEYS $11.67
- Revenue Growth
- TNGX 15.67
- WEYS N/A
- 52 Week Low
- TNGX $2.59
- WEYS $27.05
- 52 Week High
- TNGX $12.89
- WEYS $41.05
- Technical
- Relative Strength Index (RSI)
- TNGX 58.01
- WEYS 46.19
- Support Level
- TNGX $2.82
- WEYS $34.32
- Resistance Level
- TNGX $3.20
- WEYS $37.25
- Average True Range (ATR)
- TNGX 0.20
- WEYS 1.00
- MACD
- TNGX 0.05
- WEYS -0.06
- Stochastic Oscillator
- TNGX 97.40
- WEYS 31.40
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About WEYS Weyco Group Inc.
Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale and the North American retail segment. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.